Global epigenetics market to grow by $1.47b until 2028

The market is expected to project a 14.75% CAGR within the forecast period.

The global epigenetics market is projected to grow by $1.47b until 2028 at a compound annual growth rate (CAGR) of 14.75%.

A report by Technavio revealed that the market’s growth is due to the rising prevalence of chronic diseases and the demand for personalised medicine.

Moreover, Enzyme technology is a key driver for the market’s expansion.

ALSO READ: Global healthcare analytics market to reach $66.54b by 2028

By application, the oncology segment is set to witness notable market share growth within the forecast period due to a global increase in cancer cases.

“Epigenetic processes, such as DNA methylation and histone modification, play a crucial role in various diseases, including cancers,” the report said.